Connection

Jacques Izopet to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about Antiretroviral Therapy, Highly Active.
Jacques Izopet
Connection Strength
0.197
Antiretroviral Therapy, Highly Active
  1. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 11 28; 67(12):1883-1889.
    View in: PubMed
    Score: 0.124
  2. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study. J Antimicrob Chemother. 2017 06 01; 72(6):1769-1773.
    View in: PubMed
    Score: 0.028
  3. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunol. 2016 09; 9(5):1137-50.
    View in: PubMed
    Score: 0.026
  4. Antiviral effect of maraviroc in semen: a case report. Antivir Ther. 2012; 17(5):933-6.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.